Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target - Apps, J R; Carreno, G; Gonzalez-Meljem, J M (Acta Neuropathol, 2018)
et al.